Healthcare provider profile · identity verified

Alan L Morgan, M.D.

Internal Medicine · ASHEVILLE, NC · NPI 1245220532

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	549	149
Rosuvastatin Calcium	Rosuvastatin Calcium	522	143
Atorvastatin Calcium	Atorvastatin Calcium	517	131
Amlodipine Besylate	Amlodipine Besylate	463	120
Levothyroxine Sodium	Levothyroxine Sodium	441	117
Metoprolol Succinate	Metoprolol Succinate	334	85
Lisinopril	Lisinopril	287	73
Omeprazole	Omeprazole	271	79
Shingrix	Varicella-Zoster Ge/As01b/Pf	261	218
Gabapentin	Gabapentin	233	60
Hydrochlorothiazide	Hydrochlorothiazide	221	58
Simvastatin	Simvastatin	220	59
Pantoprazole Sodium	Pantoprazole Sodium	176	46
Sertraline Hcl	Sertraline Hcl	170	48
Trazodone Hcl	Trazodone Hcl	167	38
Potassium Chloride	Potassium Chloride	159	45
Metformin Hcl Er	Metformin Hcl	145	36
Eliquis	Apixaban	138	34
Escitalopram Oxalate	Escitalopram Oxalate	135	39
Pravastatin Sodium	Pravastatin Sodium	132	38
Arexvy	Rsvpref3 Antigen/As01e/Pf	129	129
Famotidine	Famotidine	126	40
Tamsulosin Hcl	Tamsulosin Hcl	126	40
Duloxetine Hcl	Duloxetine Hcl	118	27
Lorazepam	Lorazepam	116	20
Allopurinol	Allopurinol	111	33
Meloxicam	Meloxicam	103	28
Tramadol Hcl	Tramadol Hcl	101	15
Valsartan	Valsartan	101	29
Furosemide	Furosemide	94	30
Zolpidem Tartrate	Zolpidem Tartrate	94	44
Citalopram Hbr	Citalopram Hydrobromide	87	24
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	82	82
Jardiance	Empagliflozin	77	16
Bupropion Xl	Bupropion Hcl	75	19
Metformin Hcl	Metformin Hcl	74	20
Synthroid	Levothyroxine Sodium	74	21
Clopidogrel	Clopidogrel Bisulfate	71	17
Fluticasone Propionate	Fluticasone Propionate	71	27
Metoprolol Tartrate	Metoprolol Tartrate	69	22
Montelukast Sodium	Montelukast Sodium	68	22
Fluoxetine Hcl	Fluoxetine Hcl	66	17
Benazepril Hcl	Benazepril Hcl	65	14
Alprazolam	Alprazolam	64	23
Clonazepam	Clonazepam	64	14
Ezetimibe	Ezetimibe	64	16
Spironolactone	Spironolactone	60	19
Donepezil Hcl	Donepezil Hcl	59	19
Carvedilol	Carvedilol	54	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	14
Anastrozole	Anastrozole	50	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	15
Venlafaxine Hcl Er	Venlafaxine Hcl	48	11
Estradiol	Estradiol	47	14
Fenofibrate	Fenofibrate	47	13
Ozempic	Semaglutide	46	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	14
Warfarin Sodium	Warfarin Sodium	43	11
Valacyclovir	Valacyclovir Hcl	42	14
Xarelto	Rivaroxaban	41	suppressed
Mirtazapine	Mirtazapine	40	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	40	suppressed
Glimepiride	Glimepiride	38	11
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	18
Atenolol	Atenolol	37	suppressed
Finasteride	Finasteride	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	13
Alendronate Sodium	Alendronate Sodium	33	13
Tramadol Hcl Er	Tramadol Hcl	32	suppressed
Ibandronate Sodium	Ibandronate Sodium	31	12
Temazepam	Temazepam	31	suppressed
Celecoxib	Celecoxib	29	12
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Linzess	Linaclotide	26	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Prednisone	Prednisone	19	suppressed
Azithromycin	Azithromycin	18	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Diazepam	Diazepam	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Silodosin	Silodosin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error